Azatadine (Optimine) is a first-generation antihistamine and anticholinergic drug that was synthesized in 1963 by Schering-Plough, a former American pharmaceutical company.[1][2]
Clinical data | |
---|---|
Trade names | Optimine |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C20H22N2 |
Molar mass | 290.410 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |
It was patented in 1967.[3] It has been succeeded by both loratadine and desloratadine.[4]: 53 and marketing approvals have been widely withdrawn.[5][6][7][8]: 290 [9]